Unison Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $669K | Hold |
5,327
| – | – | 0.07% | 132 |
|
|
2025
Q1 | $729K | Buy |
5,327
+249
| +5% | +$34.1K | 0.09% | 116 |
|
|
2024
Q4 | $777K | Hold |
5,078
| – | – | 0.09% | 113 |
|
|
2024
Q3 | $984K | Hold |
5,078
| – | – | 0.12% | 87 |
|
|
2024
Q2 | $1.18M | Hold |
5,078
| – | – | 0.15% | 77 |
|
|
2024
Q1 | $1.09M | Hold |
5,078
| – | – | 0.11% | 84 |
|
|
2023
Q4 | $1.31M | Hold |
5,078
| – | – | 0.14% | 75 |
|
|
2023
Q3 | $1.31M | Hold |
5,078
| – | – | 0.15% | 70 |
|
|
2023
Q2 | $1.45M | Hold |
5,078
| – | – | 0.16% | 70 |
|
|
2023
Q1 | $1.41M | Hold |
5,078
| – | – | 0.16% | 70 |
|
|
2022
Q4 | $1.41M | Hold |
5,078
| – | – | 0.18% | 74 |
|
|
2022
Q3 | $1.36M | Hold |
5,078
| – | – | 0.25% | 68 |
|
|
2022
Q2 | $1.04M | Hold |
5,078
| – | – | 0.27% | 72 |
|
|
2022
Q1 | $1.07M | Hold |
5,078
| – | – | 0.26% | 73 |
|
|
2021
Q4 | $1.22M | Hold |
5,078
| – | – | 0.29% | 69 |
|
|
2021
Q3 | $1.44M | Sell |
5,078
-1,350
| -21% | -$382K | 0.36% | 64 |
|
|
2021
Q2 | $2.23M | Buy |
6,428
+527
| +9% | +$182K | 0.41% | 57 |
|
|
2021
Q1 | $1.65M | Hold |
5,901
| – | – | 0.32% | 66 |
|
|
2020
Q4 | $1.45M | Hold |
5,901
| – | – | 0.33% | 67 |
|
|
2020
Q3 | $1.67M | Hold |
5,901
| – | – | 0.48% | 55 |
|
|
2020
Q2 | $1.58M | Buy |
5,901
+177
| +3% | +$47.4K | 0.53% | 62 |
|
|
2020
Q1 | $1.81M | Buy |
+5,724
| New | +$1.81M | 1.95% | 4 |
|